Cochlear Ltd (Cochlear) is a medical device company that offers implantable hearing solutions to the customers. It develops, manufactures, and markets electronic implantable hearing devices. The company’s products are suited for people with hearing loss caused by ear nerve damage. Its major products include cochlear implant systems, bone conduction systems, acoustic implants, bone anchored prosthetics and wireless accessories including wireless mini microphone, wireless phone clip and wireless television streamer. It has manufacturing facilities and regional distribution centers in North America and Europe. The company conducts its operations in the Asia-Pacific, Americas, the Middle East and Europe. The company markets its products through subsidiaries, local offices, distributors and agents. Cochlear is headquartered in Sydney, New South Wales, Australia.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Cochlear Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- Cochlear Ltd Company Overview
- Cochlear Ltd Company Snapshot
- Cochlear Ltd Pipeline Products and Ongoing Clinical Trials Overview
- Cochlear Ltd - Pipeline Analysis Overview
- Business Description
- Cochlear Ltd - Key Facts
- Cochlear Ltd - Major Products and Services
- Cochlear Ltd Pipeline Products by Development Stage
- Cochlear Ltd Ongoing Clinical Trials by Trial Status
- Cochlear Ltd Pipeline Products Overview
- Cochlear Implant With Dexamethasone Eluting Electrode Array
- Cochlear Implant With Dexamethasone Eluting Electrode Array Product Overview
- Cochlear Osia OSI300 Implant
- Cochlear Osia OSI300 Implant Product Overview
- CP1110 Sound Processor
- CP1110 Sound Processor Product Overview
- Custom Sound Pro Fitting Software
- Custom Sound Pro Fitting Software Product Overview
- Nucleus 7 Sound Processor For Nucleus 22 Implant
- Nucleus 7 Sound Processor For Nucleus 22 Implant Product Overview
- Nucleus Kanso 2 Sound Processor
- Nucleus Kanso 2 Sound Processor Product Overview
- Nucleus Kanso 2 Sound Processor Clinical Trial
- Nucleus Profile Plus
- Nucleus Profile Plus Product Overview
- Nucleus SmartNav System
- Nucleus SmartNav System Product Overview
- OSIA 2 System
- Product Status
- Cochlear Ltd - Key Competitors
- Cochlear Ltd - Key Employees
- Cochlear Ltd - Key Employee Biographies
- Cochlear Ltd - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Cochlear Ltd, Recent Developments
- May 27, 2022: Appointment of Karen Penrose to the Cochlear Board
- Sep 24, 2021: Cochlear advises of US patent infringement complaint
- Mar 18, 2021: Cochlear announces next phase in development of a cochlear implant with drug eluting electrode technology
- Feb 12, 2021: Cochlear Appoints Stu Sayers as CFO
- May 19, 2020: Cochlear: Denial of appeal rehearing in US patent infringement case
- Dec 12, 2019: Cochlear obtains FDA approval for bone conduction implant
- Dec 11, 2019: FDA clears Cochlear's innovative new Osia 2 hearing implant system
- Dec 10, 2019: Appointment of Michael Daniell to the Cochlear Limited Board
- Nov 18, 2019: Cochlear advises of FDA clearance for the Cochlear Osia 2 System
- Oct 02, 2019: Couple discusses impact hearing loss had on relationship
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- Cochlear Ltd Pipeline Products and Ongoing Clinical Trials Overview
- Cochlear Ltd Pipeline Products by Equipment Type
- Cochlear Ltd Pipeline Products by Indication
- Cochlear Ltd Ongoing Clinical Trials by Trial Status
- Cochlear Ltd, Key Facts
- Cochlear Ltd, Major Products and Services
- Cochlear Ltd Number of Pipeline Products by Development Stage
- Cochlear Ltd Pipeline Products Summary by Development Stage
- Cochlear Ltd Ongoing Clinical Trials by Trial Status
- Cochlear Ltd Ongoing Clinical Trials Summary
- Cochlear Implant With Dexamethasone Eluting Electrode Array - Product Status
- Cochlear Implant With Dexamethasone Eluting Electrode Array - Product Description
- Cochlear Osia OSI300 Implant - Product Status
- Cochlear Osia OSI300 Implant - Product Description
- CP1110 Sound Processor - Product Status
- CP1110 Sound Processor - Product Description
- Custom Sound Pro Fitting Software - Product Status
- Custom Sound Pro Fitting Software - Product Description
- Nucleus 7 Sound Processor For Nucleus 22 Implant - Product Status
- Nucleus 7 Sound Processor For Nucleus 22 Implant - Product Description
- Nucleus Kanso 2 Sound Processor - Product Status
- Nucleus Kanso 2 Sound Processor - Product Description
- Nucleus Kanso 2 Sound Processor - A Pre-market, Open-label, Within Subject Study, of Acceptance and Performance of the CP1170 Sound Processor in Experienced Adult Cochlear Implant Recipients Compared With the CP1150 Sound Processor and Their Current Sound Processor.
- Nucleus Profile Plus - Product Status
- Nucleus Profile Plus - Product Description
- Nucleus SmartNav System - Product Status
- Nucleus SmartNav System - Product Description
- Product Status
- OSIA 2 System - Product Description
- Cochlear Ltd, Key Employees
- Cochlear Ltd, Key Employee Biographies
- Cochlear Ltd, Other Locations
- Cochlear Ltd, Subsidiaries
- Glossary
- Cochlear Ltd Pipeline Products by Equipment Type
- Cochlear Ltd Pipeline Products by Development Stage
- Cochlear Ltd Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Rion Co Ltd
- Starkey Hearing Technologies Inc
- Sonova Holding AG
- Demant A/S
- GN ReSound Pty. Ltd
- Widex Australia Pty Ltd
- MED-EL Elektromedizinische Gerate Gesellschaft mbH
- Sophono, Inc
- Sonic Innovations Pty Ltd
- Demant A/S
- Rion Co Ltd
- GN ReSound Pty. Ltd
- Sonova Holding AG
- Widex Australia Pty Ltd
- MED-EL Elektromedizinische Gerate Gesellschaft mbH
- Sophono, Inc
- Sonic Innovations Pty Ltd
- Starkey Hearing Technologies Inc
